{"id":23224,"date":"2012-12-04T18:48:04","date_gmt":"2012-12-04T18:48:04","guid":{"rendered":"http:\/\/www.eugenesis.com\/new-method-for-creating-long-lived-stem-cells-used-for-bone-replacement\/"},"modified":"2012-12-04T18:48:04","modified_gmt":"2012-12-04T18:48:04","slug":"new-method-for-creating-long-lived-stem-cells-used-for-bone-replacement-2","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/new-method-for-creating-long-lived-stem-cells-used-for-bone-replacement-2.php","title":{"rendered":"New method for creating long-lived stem cells used for bone replacement"},"content":{"rendered":"<p><p>Public  release date: 4-Dec-2012  [ |   E-mail   |  Share    ]  <\/p>\n<p>    Contact: Vicki Cohn    <a href=\"mailto:vcohn@liebertpub.com\">vcohn@liebertpub.com<\/a>    914-740-2100    Mary    Ann Liebert, Inc.\/Genetic Engineering News<\/p>\n<p>    New Rochelle, NY, December 4, 2012Human mesenchymal stem cells    (hMSCs) can develop into bone cells and are useful for tissue    engineering and regeneration. However, when grown in the    laboratory they quickly lose their ability to continue dividing    and they die. A method for genetically engineering hMSCs so    they become immortal and still retain their ability to become    bone cells is described in an article published in    BioResearch Open Access, a bimonthly peer-reviewed    journal from Mary Ann Liebert, Inc., publishers. The article is    available free on the BioResearch Open Access website at    <a href=\"http:\/\/www.liebertpub.com\/biores\" rel=\"nofollow\">http:\/\/www.liebertpub.com\/biores<\/a>.  <\/p>\n<p>    D.S. Bischoff, N.S. Makhigani, and D.T. Yamaguchi, Veterans    Administration Greater Los Angeles Healthcare System and The    David Geffen School of Medicine at University of California,    Los Angeles, inserted a gene called human telomerase (TERT)    into hMSCs. The authors provide evidence to support the ability    of human TERT to enhance the growth capacity of hMSCs in    \"Constitutive Expression of Human Telomerase Enhances the    Proliferation Potential of Human Mesenchymal Stem Cells.\" They    demonstrate that they were able to produce a stable hMSC cell    line that can be grown in culture through repeated cell    divisions and that the stem cells can differentiate into    osteoblasts for potential use in bone engineering applications.  <\/p>\n<p>    \"Generating a stable human mesenchymal stem cell line that    retains osteoblastic and adipogenic potential has important    benefits for bone engineering studies, particularly those which    require a large number of cells,\" says Editor-in-Chief Jane    Taylor, PhD, MRC Centre for Regenerative Medicine, University    of Edinburgh, Scotland.  <\/p>\n<p>    ###  <\/p>\n<p>    About the Journal  <\/p>\n<p>    BioResearch Open Access is a bimonthly peer-reviewed    open access journal that provides a new rapid-publication forum    for a broad range of scientific topics including molecular and    cellular biology, tissue engineering and biomaterials,    bioengineering, regenerative medicine, stem cells, gene    therapy, systems biology, genetics, biochemistry, virology,    microbiology, and neuroscience. All articles are published    within 4 weeks of acceptance and are fully open access and    posted on PubMedCentral. All journal content is available on    the BioResearch Open Access website at <a href=\"http:\/\/www.liebertpub.com\/biores\" rel=\"nofollow\">http:\/\/www.liebertpub.com\/biores<\/a>.  <\/p>\n<p>    About the Publisher  <\/p>\n<p>    Mary Ann Liebert, Inc., publishers (<a href=\"http:\/\/www.liebertpub.com\" rel=\"nofollow\">http:\/\/www.liebertpub.com<\/a>) is a    privately held, fully integrated media company known for    establishing authoritative peer-reviewed journals in many    promising areas of science and biomedical research, including    Tissue Engineering, Stem Cells and Development, Human Gene    Therapy and HGT Methods, and AIDS Research and Human    Retroviruses. Its biotechnology trade magazine, Genetic    Engineering & Biotechnology News (GEN), was the first    in its field and is today the industry's most widely read    publication worldwide. A complete list of the firm's 70    journals, books, and newsmagazines is available on the Mary Ann    Liebert, Inc., publishers website at <a href=\"http:\/\/www.liebertpub.com\" rel=\"nofollow\">http:\/\/www.liebertpub.com<\/a>.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>More:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2012-12\/mali-nmf120412.php\" title=\"New method for creating long-lived stem cells used for bone replacement\">New method for creating long-lived stem cells used for bone replacement<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Public release date: 4-Dec-2012 [ | E-mail | Share ] Contact: Vicki Cohn <a href=\"mailto:vcohn@liebertpub.com\">vcohn@liebertpub.com<\/a> 914-740-2100 Mary Ann Liebert, Inc.\/Genetic Engineering News New Rochelle, NY, December 4, 2012Human mesenchymal stem cells (hMSCs) can develop into bone cells and are useful for tissue engineering and regeneration. However, when grown in the laboratory they quickly lose their ability to continue dividing and they die. A method for genetically engineering hMSCs so they become immortal and still retain their ability to become bone cells is described in an article published in BioResearch Open Access, a bimonthly peer-reviewed journal from Mary Ann Liebert, Inc., publishers <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-engineering\/new-method-for-creating-long-lived-stem-cells-used-for-bone-replacement-2.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[3],"tags":[],"class_list":["post-23224","post","type-post","status-publish","format-standard","hentry","category-genetic-engineering"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/23224"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=23224"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/23224\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=23224"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=23224"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=23224"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}